Litcius/Paper detail

Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury

Dandan Zhu, Xuemei Tan, Liqing Lu, Sijia Yu, Ru-Li Jian, Xinfang Liang, Yixuan Liao, Wei Fan, Lucíia Barbier-Torres, Austin J. Yang, Heping Yang, Ting Liu

2021World Journal of Gastroenterology19 citationsDOIOpen Access PDF

Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver injury. Here, we show the novel reciprocal regulation between NRF2 and inflammatory mediators associated with COVID-19-related liver injury. Additionally, we describe some mechanisms and treatment strategies.

Topics & Concepts

InflammationLiver injuryCoronavirus disease 2019 (COVID-19)MedicineImmunologyTranscription factorCoronavirusDiseaseInternal medicineBiologyInfectious disease (medical specialty)GeneBiochemistryGenomics, phytochemicals, and oxidative stressCOVID-19 Clinical Research StudiesCalcium signaling and nucleotide metabolism